Buzz
A Medication for Narcolepsy Also Helps Combat Fatigue in Others
Approved by the FDA in 1998, modafinil was initially prescribed to treat excessive daytime sleepiness in narcolepsy patients. However, its reputation has grown significantly, attracting attention beyond those with narcolepsy. Often used off-label as a wakefulness-promoting agent, its effectiveness has sparked research that could revolutionize the future of sleep science.
The fascination with sleep is understandable in a society that struggles to get enough of it. While the average adult requires around eight hours of sleep, most only manage seven hours on workdays, with 36 percent sleeping fewer than 6.5 hours on weeknights. Additionally, 25 percent of adults have resorted to sleep aids in the past year.
Before modafinil, amphetamines like Dexedrine were the go-to stimulants for fighting sleepiness. However, these drugs come with a host of side effects, including agitation, irritability, nausea, elevated heart rate, tics, and even impotence. Moreover, their withdrawal often leads to severe fatigue or depressive episodes.
Modafinil largely avoids the typical drawbacks of sleep deprivation. "In contrast to most stimulants, it has minimal adverse effects," explains Dr. Tom Scammell, a sleep specialist and neurology professor at Beth Israel Deaconess Medical Center in Boston. Clinical trials revealed that the most frequent side effects include headaches (1 percent), nausea (1 percent), depression (1 percent), and nervousness (1 percent).
A June 2000 study in Psychopharmacologia examined how the drug impacts performance on complex tasks under sleep-deprived conditions. At the U.S. Army Aeromedical Research Laboratory in Fort Rucker, Alabama, six pilots stayed awake for two 40-hour stretches. They received modafinil during one session and a placebo during the other. Their performance was assessed through helicopter simulator flights, resting EEGs, and mood surveys. Modafinil improved performance in four out of six flight maneuvers compared to the placebo. It also reduced slow-wave EEG activity (a sign of drowsiness) and alleviated self-reported mood and alertness issues.
Modafinil: The Ultimate Wake-up Pill? (<i>cont'd</i>)
The military has a vested interest in this groundbreaking medication. Combat operations often demand prolonged wakefulness from pilots. During the Vietnam War, amphetamines became widely used by aircrews. In the Persian Gulf War, the Air Force administered Dexedrine to most flight crews, with over 60 percent deeming it "essential" for mission success.
Outside the military, the potential for a drug that enhances wakefulness and alertness without severe side effects is immense. Shift workers, individuals pursuing additional employment, or those seeking to maximize productivity could greatly benefit from such a solution.
"It enhances alertness, but its ability to maintain peak cognitive function is still uncertain," Scammell notes. "For instance, can a surgeon retain the same level of precision during an operation?"
Despite sparking significant research, the exact workings of modafinil remain largely unclear. "The core mechanism is still not well understood," Scammell explains.
Neurons, the brain's cells, use neurotransmitters such as dopamine to communicate. One neuron releases a neurotransmitter, which carries a signal to the next. These neurons perform various roles—some induce sleep, while others promote wakefulness. Recent studies suggest that sleep-inducing systems likely function by deactivating wakefulness-promoting systems, and vice versa.
Dopamine is crucial in one of the brain's pathways that promote wakefulness. Amphetamines, for example, work by inhibiting transporters, which prevents neurotransmitters from being reabsorbed into the cells that released them.
Modafinil may operate similarly by influencing dopamine, Scammell suggests. A study he conducted with colleagues revealed that the drug activated dopamine-responsive neurons in rat brains. Another study from Stanford found that rats lacking a dopamine reuptake transporter showed no response to modafinil.
Scammell expresses concern that individuals with genuine medical conditions causing sleepiness, such as sleep apnea, might turn to modafinil as a quick solution rather than seeking a thorough medical evaluation. He emphasizes that no stimulant can truly replace the necessity of sleep. "To my knowledge, no amount of stimulants can fully compensate for severe sleep deprivation," he states. "Sleep is irreplaceable."
